-
FDA approves new allergy drug for children
MONMOUTH JUNCTION, N.J. — The Food and Drug Administration has approved a new drug for allergies in children made by Tris Pharma, the drug maker said Wednesday.
Tris announced the approval of Karbinal ER (carbinoxamine maleate) extended-release oral suspension in the 4 mg-per-five milliliter strength. The company said the drug was the first sustained-release histamine receptor blocking agent for seasonal and perennial allergic rhinitis in children 2 and older.
-
Basketball All-Star Lisa Leslie joins Chattem on 'Allegra Outdoor Challenge'
BRIDGEWATER, N.J. — Basketball All-Star Lisa Leslie and Chattem last week created the "Allegra Outdoor Challenge," a series of workout tips to help inspire people to stay active outdoors during spring allergy season.
Beginning in April, Allegra's Facebook page will highlight photos and tips from Leslie detailing ways families can take the "Allegra Outdoor Challenge" and escape allergy madness this spring.